Introduce
- HOME
- ABOUT US
- Introduce
-
Shangrila Bio aims to conquer various incurable diseases using advanced regenerative medical technology and lead a healthy and beautiful life through the development of high-quality regenerative medical products.
Shangrila Bio seeks to pursue a healthy human life through the commercialization of immune cell therapy and the development of anticancer drugs to conquer incurable cancer diseases. We aim to introduce and industrialize Anti-cancer NKT immune cell therapy technology in Korea commercialized it in advanced medical countries and develop RK Anticancer drug that induces immune cell activity.
Also, we intend to develop and commercialize an efficient peptide treatment for skeletal diseases using Bone Forming Peptide (BFP), which promotes bone formation developed by our technology. And we are commercializing exosome cosmetics in Korea using high-quality exosomes obtained from cells. Currently, high-quality exosomes developed with cutting-edge technologies and exosome cosmetics using homogenized nanogold are on sale in Japan, which will start with import sales and even domestic production and sales.
Starting with immune cell therapy, Shangrila Bio will leap forward as a global bio company that leads various advanced regenerative medical technologies and will become a company that can contribute to improving the health of mankind in Korea and the world.
Shangrila Bio CEO Taek Rim, YOON